These results, together with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two help the thought of focusing on ACKR3 as a singular technique to modulate the opioid program, which could open up new therapeutic avenues for opioid-linked Issues. In response to this https://subhashn470xav4.blog-ezine.com/profile